iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Strong Trading Volume – Here’s What Happened

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) saw an uptick in trading volume on Thursday . Approximately 225,500 shares changed hands during mid-day trading, an increase of 73% from the previous session’s volume of 130,651 shares.The stock last traded at $101.13 and had previously closed at $100.64.

iShares U.S. Pharmaceuticals ETF Trading Up 0.4%

The company has a 50-day moving average price of $95.65 and a two-hundred day moving average price of $90.38. The stock has a market cap of $1.46 billion, a P/E ratio of 17.75 and a beta of 0.49.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. EFG International AG purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at $38,000. Assetmark Inc. lifted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 203.9% in the 4th quarter. Assetmark Inc. now owns 465 shares of the company’s stock worth $39,000 after acquiring an additional 312 shares during the last quarter. O Shaughnessy Asset Management LLC boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 35.0% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock worth $39,000 after purchasing an additional 120 shares during the period. Blueline Advisors LLC purchased a new position in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter worth about $41,000. Finally, Accent Capital Management LLC purchased a new position in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter worth about $42,000.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.